Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)
Clinical trial NCT00633945 · COMPLETED
Trial details
- NCT number
- NCT00633945
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-07-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.